A multi-center, open label, observational trial to evaluate efficacy and safety of stepwise insulin treatment as add-on to current OAD therapy in subjects with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms STEADY
- 22 Jul 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 23 Jun 2009 New trial record